ABALOPARATIDE

N/A

Manufactured by Radius Health, Inc.

58,437 FDA adverse event reports analyzed

Last updated: 2026-04-14

About ABALOPARATIDE

ABALOPARATIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Radius Health, Inc.. The most commonly reported adverse reactions for ABALOPARATIDE include HEADACHE, NAUSEA, DIZZINESS, FATIGUE, HEART RATE INCREASED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ABALOPARATIDE.

Top Adverse Reactions

HEADACHE4,180 reports
NAUSEA3,222 reports
DIZZINESS3,122 reports
FATIGUE2,742 reports
HEART RATE INCREASED2,139 reports
ARTHRALGIA1,802 reports
PALPITATIONS1,785 reports
BONE PAIN1,414 reports
BACK PAIN1,289 reports
PAIN1,269 reports
PRODUCT DOSE OMISSION ISSUE1,103 reports
INJECTION SITE BRUISING976 reports
PAIN IN EXTREMITY958 reports
PRODUCT DOSE OMISSION940 reports
PRODUCT QUALITY ISSUE914 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES857 reports
INJECTION SITE PAIN851 reports
VOMITING740 reports
FEELING ABNORMAL714 reports
MUSCLE SPASMS714 reports
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS696 reports
MALAISE691 reports
MYALGIA691 reports
DIARRHOEA655 reports
INTENTIONAL DOSE OMISSION638 reports
FALL610 reports
OFF LABEL USE603 reports
ABDOMINAL PAIN UPPER567 reports
ALOPECIA549 reports
ASTHENIA546 reports
INSOMNIA537 reports
ABDOMINAL DISCOMFORT534 reports
WEIGHT INCREASED509 reports
PRODUCT DOSE OMISSION IN ERROR474 reports
ILLNESS464 reports
CONSTIPATION456 reports
CONDITION AGGRAVATED433 reports
BLOOD PRESSURE INCREASED424 reports
INTENTIONAL PRODUCT MISUSE396 reports
THERAPY INTERRUPTED396 reports
VERTIGO393 reports
ABDOMINAL DISTENSION386 reports
DECREASED APPETITE385 reports
DYSPNOEA373 reports
INJECTION SITE ERYTHEMA373 reports
MIGRAINE370 reports
PRURITUS363 reports
RASH344 reports
WEIGHT DECREASED342 reports
CHEST PAIN339 reports
FLUSHING323 reports
ANXIETY321 reports
PERIPHERAL SWELLING321 reports
GAIT DISTURBANCE318 reports
CONTUSION309 reports
TREMOR309 reports
INJECTION SITE HAEMORRHAGE308 reports
SOMNOLENCE304 reports
HYPOTENSION302 reports
MUSCULAR WEAKNESS296 reports
TACHYCARDIA293 reports
PRODUCT STORAGE ERROR291 reports
POLLAKIURIA289 reports
BLOOD CALCIUM INCREASED283 reports
NECK PAIN279 reports
BLOOD PRESSURE DECREASED276 reports
SPINAL FRACTURE274 reports
CHEST DISCOMFORT273 reports
HYPERTENSION269 reports
ABDOMINAL PAIN265 reports
JOINT SWELLING257 reports
INJECTION SITE REACTION254 reports
BALANCE DISORDER247 reports
PAIN IN JAW244 reports
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE244 reports
SLEEP DISORDER233 reports
URINARY TRACT INFECTION233 reports
PARAESTHESIA228 reports
CHILLS226 reports
INJECTION SITE PRURITUS223 reports
PRODUCT USE COMPLAINT223 reports
HEAD DISCOMFORT222 reports
PRODUCT USE IN UNAPPROVED INDICATION222 reports
SENSORY DISTURBANCE222 reports
MEMORY IMPAIRMENT217 reports
DEATH213 reports
ERYTHEMA208 reports
DRUG DOSE OMISSION203 reports
PNEUMONIA203 reports
DYSPEPSIA199 reports
NEEDLE ISSUE191 reports
PYREXIA188 reports
URTICARIA187 reports
HOT FLUSH175 reports
ADVERSE EVENT174 reports
DRUG INEFFECTIVE171 reports
HYPERSENSITIVITY168 reports
MUSCULOSKELETAL STIFFNESS167 reports
NASOPHARYNGITIS165 reports
FEELING HOT159 reports

Report Outcomes

Out of 24,664 classified reports for ABALOPARATIDE:

Serious 16.3%Non-Serious 83.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female22,772 (95.1%)
Male1,168 (4.9%)
Unknown4 (0.0%)

Reports by Age

Age 64513 reports
Age 63469 reports
Age 62433 reports
Age 60415 reports
Age 61392 reports
Age 65391 reports
Age 71378 reports
Age 67376 reports
Age 70352 reports
Age 66344 reports
Age 72332 reports
Age 69330 reports
Age 68323 reports
Age 73318 reports
Age 74316 reports
Age 75309 reports
Age 59305 reports
Age 76303 reports
Age 58288 reports
Age 57251 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ABALOPARATIDE?

This profile reflects 58,437 FDA FAERS reports that mention ABALOPARATIDE. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ABALOPARATIDE?

Frequently reported terms in FAERS include HEADACHE, NAUSEA, DIZZINESS, FATIGUE, HEART RATE INCREASED, ARTHRALGIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ABALOPARATIDE?

Labeling and FAERS entries often list Radius Health, Inc. in connection with ABALOPARATIDE. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.